维普中文期刊产品整合服务
48篇 您的检索式:作者名="Felding C"
    题名 作者 年代 出处 被引量
1CO2 laser vaporization in the treatment of cervical human papilloma virus in women with abnormal papanicolaou smears显示文摘Ruge S Felding C Skouby SO 1992Gynecol Obstet Ivest1992,34,3:2
2Clinical practice guideline, Otitis media with effusion显示文摘Rosen Feld RM Pepperl C Do Yle K J 2004Otolaryngol Head Neck Surg2004,130,5:1
3International multicenter random- ized phas study of first-line erlotinib (E) followed by second-line cisplatin plus gemcitabine (CG) versus first-line CG followed by sec- ond-line E in advanced non-small cell lung cancer (aNSCLC):The TORCH trial显示文摘Gridelli C Ciardiello F Feld R 2010J Clin Oncol2010,28,15:1
4Influence of alcohol intake on postoperative morbidity after hysterectomy显示文摘Felding C Jensen LM Tonnesen H 1992Am J Obstet Gynecol1992,166,7:1
5E strogen selectively up regulates eNOS and nNOS in reproductive arteries by transcrip-tional mechanisms显示文摘Rosen feld C R C hen C Roy T 2003J Soc Gyneco Ⅰ Invest2003,10,4:1
6Evaluation of a monoelonal blocking ELISA and IHA for antibodies to Mycoplasma hyopneumoni- ae in SPF - pig herds显示文摘SORENSEN V BARFOD K FELD N C 1992Vet Ree1992,130,22:1
7Autonomic activity during dexmedetomidine or fentanyl infusion with desflurane anesthesia显示文摘Feld J Hoffman WE Paisansathan C 2007J Clin Anesth2007,19,1:1
8Detecting measurement bias in respondent reports of personal networks显示文摘FELD S L CARTER W C 2002Social Networks2002,24,:1
9The impact of referendums on the centralization of public goods provi- sion: A political economy approach 显示文摘Schnellenbach J Feld L P Schaltegger C 2010Economics of Governance2010,11,:1
10International multicenter phase Ⅲ study of first-line erlotinib(E) followed by second-line cisplatin plus gemcitabine (CG) versus first-line CG followed by second-fine E in advanced non-small cell lung cancer (aNSCLC): The TORCH trial显示文摘Gridelli C Ciardiello F Feld R 2010Proc Am Soc Clin Oncol2010,28,18:1
11Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection 显示文摘Feld JJ Jacobson IM Hézode C 2015N Engl J Med2015,373,:1
12Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis显示文摘O′Brien C Joshi S Feld JJ 0,,:1
13Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of osteoclast activi- ty in the early phase after cementless total hip replacement显示文摘Habermann B Eberhardt C Feld M 2007Acta Orthopaedica2007,78,2:1
14Getting IT Right 显示文摘C S Feld D B Stoddard 2004Harvard Business Review2004,82,2:1
15International multicenter randomized phase III study of first-line erlotinib(E)followed by second-line cisplatin plus gemcitabine(CG)versus firstline CG followed by second-line E in advanced non-small cell lung cancer(aNSCLC):The TORCH trial显示文摘Gridelli C Ciardiello F Feld R 2010J Clin Oncol2010,28,5:1
16International multicenter randomized phaseⅢ study of first-line erlotinib(E)followed by second-line cisplatin plus gemcitabine(CG)versus first-line CG followed by second-line E in advanced non-small cell lung cancer(aNSCLC):The TORCH trial显示文摘GRIDELLI C CIARDIELLO F FELD R 2010J Clin Oncol2010,28,155:1
17International multicenter randomized phase Ⅲ study of first-line erlotinib (E) followed by second-line cisplatin plus gemcitabine (CG) versus first-line CG followed by second-line E in advanced non-small cell lung cancer (aNSCLC) : The TORCH trial显示文摘Gridelli C Ciardiello F Feld R 2010J Clin Oncol2010,,:1
18A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniae 显示文摘Feld N C Qvist P Ahrens P 1992Vet Microbiol1992,30,1:1
192010, Lessons from practice: assessing early progress and success in river rehabilitation 显示文摘MATTHEWS J REEZE B FELD C K 2010Hydrobiologia2010,655,1:1
20International multicenterrandomized phase DI study of first-line erlotinib ( E) followed bysecond-line cisplatin plus gemcitabine ( CG) versus first-line CGfollowed by second-line E in advanced non-small cell lung cancer(aNSCLC) : The TORCH trial显示文摘Gridelli C Ciardiello F Feld R 2010J Clin Oncol2010,28,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费